Granules India announced on Tuesday that its US subsidiary, Granules Pharmaceuticals, Inc (GPI), has received approval from the US Food and Drug Administration (USFDA) for its abbreviated new drug

Aurobindo Pharma shares opened at Rs 1,225 and touched a high of Rs 1,247.30, reflecting its robust market presence.

Geojit Financial Services has reaffirmed its BUY recommendation for Cipla Ltd., assigning a revised target price of Rs. 1,695. This valuation is based on a 26x FY26E adjusted EPS.

Biocon share price jumped nearly 4 percent during early trades as the company received FDA approval for biosimilar drug Yesintek. Biocon touched intraday high of Rs 380 after opening at Rs 375.

Natco Pharma Stock Price was trading 5.5 percent higher in early session on Monday. The stock touched intraday high of Rs 1,455 at the time of publication of this report.

Sun Pharmaceutical Industries jumped during the afternoon session with the stock price gaining over 3 percent.